Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Amvuttra (vutrisiran)
.
Show all posts
Showing posts with label
Amvuttra (vutrisiran)
.
Show all posts
Thursday, July 21, 2022
FDA Approves Amvuttra (vutrisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
›
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administrat...
›
Home
View web version
